Coload Optimization Guided by Inferior Vena Cava Collapsibility Index
NCT04272632
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
168
Enrollment
OTHER
Sponsor class
Conditions
Adverse Effect
Interventions
DRUG:
4 ml/kg group
DRUG:
8 ml/kg group
DRUG:
12 ml/kg group
Sponsor
General Hospital of Ningxia Medical University